Atlas Trials

Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease

Clinical trial NCT06218342 · UNKNOWN

Trial details

NCT number
NCT06218342
Sponsor
Sir Run Run Shaw Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DiabetesNon-Alcoholic Fatty Liver Disease
Start date
2024-02-15
Primary completion
2025-12-31
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.